Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – FCSC, PRTO, ARTX, ROAN
November 01, 2019 at 14:40 PM EDT
NEW YORK, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:
Fibrocell Science, Inc. (NASDAQ: FCSC)
Proteon Therapeutics, Inc. (NASDAQ: PRTO)
Arotech Corporation (NASDAQ: ARTX)
Roan Resources, Inc. (NYSE: ROAN)
On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email firstname.lastname@example.org or email@example.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.